AVALIA IMMUNOTHERAPIES
Avalia Immunotherapies is a developer of immune therapies that support the treatment and prevention of infectious disease and cancer.
AVALIA IMMUNOTHERAPIES
Social Links:
Industry:
Health Care Medical Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Kelburn, Wellington, New Zealand
Country:
New Zealand
Website Url:
http://www.avaliaimmunotherapies.com
Total Employee:
11+
Status:
Active
Contact:
64 27 349 9777
Technology used in webpage:
Euro Australian Server Location
Similar Organizations
Abacus Bioscience
Abacus Bioscience specializes in developing immunotherapies for treating chronic infectious diseases and cancers.
Active Back Care
Active Back Care is a healthcare center that specializes in treating and preventing back pain, neck pain, and sports injuries.
![]()
Nuo Therapeutics
Nuo Therapeutics develops biological therapies to address the areas of wound care, inflammation, and angiogenesis.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
PTM Therapeutics
PTM Therapeutics creates and develops therapies for the treatment of chronic diseases and cancer.
Sionna Therapeutics
Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).
Stem Cell Medicine
Stem Cell Medicine is a developer of cellular therapies in tissue repair and for the treatment of inflammatory disorders.
![]()
Theraclone Sciences
Theraclone Sciences is a biotech company developing novel therapeutic antibodies for the treatment of infectious diseases and inflammation.
Validus Cellular Therapeutics
Validus Cellular Therapeutics is a developer of therapeutic solutions for treating infectious diseases.
Official Site Inspections
http://www.avaliaimmunotherapies.com
- Host name: s343.syd1.hostingplatform.net.au
- IP address: 103.27.34.133
- Location: Gold Coast Australia
- Latitude: -27.9997
- Longitude: 153.4344
- Timezone: Australia/Brisbane
- Postal: 4217

More informations about "Avalia Immunotherapies"
Avalia Immunotherapies - Crunchbase Company Profile & Funding
Avalia Immunotherapies is a developer of immune therapies that support the treatment and prevention of infectious disease and cancer.See details»
Avalia Immunotherapies - a New Zealand Research ... - KiwiNet
Avalia Immunotherapies. Avalia Immunotherapies is fighting cancer, hepatitis, and now COVID-19. Avalia has fast become New Zealand's leader in immunotherapies and vaccine development.See details»
Avalia Immunotherapies - PitchBook
Avalia Immunotherapies General Information Description. Developer of immune system modulators designed to support cancer treatment. The company's modulators help in the โฆSee details»
Avalia Immunotherapies Limited | Wellington, New Zealand โฆ
At her roles in a NZ research institute (2001-2007) she managed commercialisation activities and pre-seed funds. Since 2012, she held executive roles in healthcare start-ups, growing โฆSee details»
AVALIA IMMUNOTHERAPIES LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for AVALIA IMMUNOTHERAPIES LIMITED of Lower Hutt, GREATER WELLINGTON. Get the latest โฆSee details»
Avalia Immunotherapies Company Profile | Management and
Www.avaliaimmunotherapies.com . Contact Information. Headquarters. 69 Gracefield Rd, Lower Hutt, 5010, New Zealand (917) 703-9130. Avalia Immunotherapies Profile and History . Avalia โฆSee details»
Avalia Immunotherapies - 2025 Company Profile - Tracxn
Mar 12, 2025 Avalia Immunotherapies - Developing vaccines (cancer-specific peptides & immune system activator) to treat cancer.. Raised funding from 14 investors. Founded by โฆSee details»
AVALIA IMMUNOTHERAPIES LIMITED :: New Zealand
Free and open company data on New Zealand company AVALIA IMMUNOTHERAPIES LIMITED (company number 5625065), Level 9 Tower Centre, 45 Queen Street, Auckland, 1010See details»
Avalia Immunotherapies Ltd. - Drug pipelines, Patents, Clinical โฆ
Explore Avalia Immunotherapies Ltd. with its drug pipeline, therapeutic area, technology platform, 4 literature, Disease Domain:Infectious Diseases, Technology ...See details»
AVALIA IMMUNOTHERAPIES LIMITED (NZBN: 9429041643075)
Mar 13, 2015 Company details for AVALIA IMMUNOTHERAPIES LIMITED, NZBN 9429041643075See details»
Avalia Immunotherapies Profile - medical-xprt.com
We develop immune system modulators that activate and direct the most powerful immune cells in the body for targeted responses to disease. Our underpinning science originates from two of โฆSee details»
Avalia Immunotherapies - Craft
Avalia Immunotherapies has 1 employees across 2 locations. See insights on Avalia Immunotherapies including office locations, competitors, revenue, financials, executives, โฆSee details»
Avalia Immunotherapies - Products, Competitors, Financials, โฆ
Avalia Immunotherapies focuses on the development of immune therapies within the biotechnology sector. Use the CB Insights Platform to explore Avalia Immunotherapies's full โฆSee details»
Avalia Immunotherapies - Overview, News & Competitors
View Avalia Immunotherapies (www.avaliaimmunotherapies.com) location in New Zealand , revenue, industry and description. Find related and similar companies as well as employees โฆSee details»
Avalia Immunotherapies - VentureRadar
Similar Companies: Vaxon Biotech France Privately Held Vaxon Biotech is a developer of therapeutic vaccines designed to offer treatment for cancer. The company's vaccines are โฆSee details»
Avalia Immunotherapies - FirstXFounder
Avalia Immunotherapies โ A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious โฆSee details»
New immunotherapy technology company launched - Yahoo โฆ
May 20, 2015 An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellingtonโs Ferrier Research Institute and the Malaghan โฆSee details»
Avalia Immunotherapies | CipherBio
Explore Avalia Immunotherapies's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Avalia Immunotherapies to advance immunotherapy technology
21 May 2015 An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellingtonโs Ferrier Research Institute and the Malaghan โฆSee details»
Autoimmune Disease Treatment and Management
Organization. Office of the Director. Division of AIDS. Division of Allergy, Immunology, and Transplantation . Division of Microbiology and Infectious Diseases. Division of Extramural โฆSee details»